Constrictor prostanoids and uridine adenosine tetraphosphate: Vascular mediators and therapeutic targets in hypertension and diabetes

British Journal of Pharmacology

Volumn 172, Issue 16, 2015, Pages 3980-4001

  Matsumoto, Takayuki ^a   Goulopoulou, Styliani ^b   Taguchi, Kumiko ^a   Tostes, Rita C ^c   Kobayashi, Tsuneo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Fort Worth Texas College of Osteopathic Medicine   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 5 AMINOIMIDAZOLE 4 CARBOXAMIDE 1 BETA DEXTRO RIBOFURANSIDE; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; ESTROGEN RECEPTOR; HEMIN; IBUPROFEN; ICOSAPENTAENOIC ACID; IMIDAZOLE DERIVATIVE; LOSARTAN; METFORMIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE; PRAVASTATIN; PROSTAGLANDIN SYNTHASE; PROSTANOID; PYRROLIDINE DITHIOCARBAMATE; ROFECOXIB; SEX HORMONE; TAUROURSODEOXYCHOLIC ACID; THROMBOXANE A2; THROMBOXANE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE ADENOSINE TETRAPHOSPHATE; DINUCLEOSIDE PHOSPHATE; ENDOTHELIN; PROSTAGLANDIN;

CARDIOVASCULAR RESPONSE; COMPLEX FORMATION; DIABETES CONTROL; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR CALCIUM; GENE EXPRESSION REGULATION; HUMAN; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; ANIMAL; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE CELL;

ANIMALS; DIABETES MELLITUS; DINUCLEOSIDE PHOSPHATES; ENDOTHELINS; GONADAL STEROID HORMONES; HUMANS; HYPERTENSION; MYOCYTES, SMOOTH MUSCLE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; VASOCONSTRICTION;

EID: 84937519768     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13205     Document Type: Review

References (287)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, et al. (2006). International union of pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58: 281-341.
2. Akamine EH, Urakawa TA, de Oliveira MA, Nigro D, de Carvalho MH, de Cassia A, et al. (2006). Decreased endothelium-dependent vasodilation in diabetic female rats: role of prostanoids. J Vasc Res 43: 401-410.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al., CGTP Collaborators. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al., CGTP Collaborators. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Ligand-gated ion channels. Br J Pharmacol 170: 1607-1651.
5. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013c). The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
6. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al., CGTP Collaborators. (2013d). The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors. Br J Pharmacol 170: 1676-1705.
7. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al., CGTP Collaborators. (2013e). The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors. Br J Pharmacol 170: 1652-1675.
8. Alfranca A, Iniguez MA, Fresno M, Redondo JM, (2006). Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular disease. Cardiovasc Res 70: 446-456.
9. Almabrouk TA, Ewart MA, Salt IP, Kennedy S, (2014). Perivascular fat, AMP-activated protein kinase and vascular diseases. Br J Pharmacol 171: 595-617.
10. Aloysius UI, Achike FI, Mustafa MR, (2012). Mechanisms underlining gender differences in phenylephrine contraction of normoglycaemic and short-term streptozotocin-induced diabetic WKY rat aorta. Vascul Pharmacol 57: 81-90.
11. Amer M, Bead VR, Bathon J, Blumenthal RS, Edwards DN, (2010). Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale. Cardiol Rev 18: 204-212.
12. Arnal JF, Fontaine C, Billon-Gales A, Favre J, Laurell H, Lenfant F, et al. (2010). Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol 30: 1506-1512.
13. Asano H, Shimizu K, Muramatsu M, Iwama Y, Toki Y, Miyazaki Y, et al. (1994). Prostaglandin H2 as an endothelium-dependent contracting factor modulates endothelin-1-induced contraction. J Hypertens 12: 383-390.
14. 2 receptor antagonists inhibit endothelium-dependent contractions. Hypertension 15: 699-703.
15. Bagi Z, Erdei N, Toth A, Li W, Hintze TH, Koller A, et al. (2005). Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostanoids. Arterioscler Thromb Vasc Biol 25: 1610-1616.
16. Bagi Z, Erdei N, Papp Z, Edes I, Koller A, (2006). Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus. Pharmacol Rep 58 (Suppl.): 52-56.
17. Balakumar P, Taneja G, (2012). Fish oil and vascular endothelial protection: bench to bedside. Free Radic Biol Med 53: 271-279.
18. Baretella O, Chung SK, Barton M, Xu A, Vanhoutte PM, (2014). Obesity and heterozygous endothelial overexpression of prepro-endothelin-1 modulate responsiveness of mouse main and segmental renal arteries to vasoconstrictor agents. Life Sci 118: 206-212.
19. Barton M, (2010). Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis. Pflugers Arch 460: 825-837.
20. Barton M, Beretella O, Meyer MR, (2012). Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol 165: 591-602.
21. Bauer J, Ripperger A, Frantz S, Ergun S, Schwedhelm E, Benndorf RA, (2014). Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation. Br J Pharmacol 171: 3115-3131.
22. Bazi Z, Feher A, Cassuto J, (2012). Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol 165: 544-560.
23. Belhassen L, Pelle G, Dubois-Rande JL, Adnot S, (2003). Improved endothelial function by the thromboxane A2 receptor antagonist S18886 in patients with coronary artery disease treated with aspirin. J Am Coll Cardiol 41: 1198-1204.
24. Bolego C, Buccellanti C, Radaelli T, Cetin I, Puglisi L, Folco G, et al. (2006). eNOS, COX-2, and prostacyclin production are impaired in endothelial cells from diabetics. Biochem Biophys Res Commun 339: 188-190.
25. Bolla M, Matrougui K, Loufrani L, Maclouf J, Levy B, Levy-Toledano S, et al. (2002). p38 mitogen-activated protein kinase activation is required for thromboxane- induced contraction in perfused and pressurized rat mesenteric resistance arteries. J Vasc Res 39: 353-360.
26. Bruder-Nascimento T, da Silva MA, Tostes RC, (2014). The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes. Diabetol Metab Syndr 6: 90.
27. Bubb KJ, Khambata RS, Ahluwalia A, (2012). Sexual dimorphism in rodent models of hypertension and atherosclerosis. Br J Pharmacol 167: 298-312.
28. Bunimov N, Laneuville O, (2008). Cyclooxygense inhibitors: instrumental drugs to understand cardiovascular homeostasis and arterial thrombosis. Cardiovasc Hematol Disord Drug Targets 8: 268-277.
29. Burger NZ, Kuzina OY, Osol G, Gokina NI, (2009). Estrogen replacement enhances EDHF-mediated vasodilation of mesenteric and uterine resistance arteries: role of endothelial cell Ca2+. Am J Physiol Endocrinol Metab 296: E503-E512.
30. Burnstock G, (2007). Purine and pyrimidine receptors. Cell Mol Life Sci 64: 1471-1483.
31. Burnstock G, Ralevic V, (2013). Purinergic signaling and blood vessels in health and disease. Pharmacol Rev 66: 102-192.
32. Calder PC, (2012). Mechanisms of action of (n-3) fatty acids. J Nutr 142: 592S-599S.
33. Campia U, Tesauro M, Cardillo C, (2012). Human obesity and endothelium-dependent responsiveness. Br J Pharmacol 165: 561-573.
34. Cau SB, Guimaraes DA, Rizzi E, Ceron CS, Souza LL, Tirapelli CR, et al. (2011). Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodeling in renovascular hypertension. Br J Pharmacol 164: 372-381.
35. Chamorro A, (2009). TP receptor antagonism: a new concept in atherothrombosis and stroke prevention. Cerebrovasc Dis 27 (Suppl. 3): 20-27.
36. Chan CK, Mak JC, Man RY, Vanhoutte PM, (2009). Rho kinase inhibitors prevent endothelium-dependent contractions in the aorta. J Pharmacol Exp Ther 329: 820-826.
37. Chan YC, Leung FP, Yao X, Lau CW, Vanhoutte PM, Huang Y, (2007). Raloxifene modulates pulmonary vascular reactivity in spontaneously hypertensive rats. J Cardiovasc Pharmacol 49: 355-361.
38. Chen G, Suzuki H, Weston AH, (1988). Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 95: 1165-1174.
39. Chen NX, Moe SM, (2012). Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep 14: 228-237.
40. Cheuk BL, Leung PS, Lo AC, Wong PY, (2000). Androgen control of cyclooxygenase expression in the rat epididymis. Biol Reprod 63: 775-780.
41. Chignalia AZ, Oliveira MA, Debbas V, Dull RO, Laurindo FR, Touyz RM, et al. (2015). Testosterone induces leukocyte migration by NADPH oxidase-driven ROS- and COX2-dependent mechanisms. Clin Sci 129: 39-48.
42. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, et al. (2003). High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107: 1017-1023.
43. Costa SG, Anversa P, Scavone C, Sucupira M, Carvalho MHC, (1998). Nitric oxide synthase activity in microvessels of SHR and normotensive rats: effects of estrogen. J Hypertens 25: S80.
44. Crane GJ, Garland CJ, (2004). Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery. Br J Pharmacol 142: 43-50.
45. Dantas AP, Scivoletto R, Fortes ZB, Nigro D, Carvalho MH, (1999). Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats. Hypertension 34: 914-919.
46. Davi G, Santilli F, Vazzana N, (2012). Thromboxane receptors antagonists and/or synthase inhibitors. Handb Exp Pharmacol 210: 261-286.
47. Davidge ST, Zhang Y, (1998). Estrogen replacement suppresses a prostaglandin H synthase-dependent vasoconstrictor in rat mesenteric arteries. Circ Res 83: 388-395.
48. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM, (2000). Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974.
49. Del Turco S, Basta G, Lazzerini G, Chancharme L, Lerond L, De Caterina R, (2014). Involvement of the TP receptor in TNF-α-induced endothelial tissue factor expression. Vascul Pharmacol 62: 49-56.
50. Denniss SG, Jeffery AJ, Rush JW, (2010). RhoA-Rho kinase signaling mediates endothelium- and endoperoxidase-dependent contractile activities characteristic of hypertensive vascular dysfunction. Am J Physiol Heart Circ Physiol 298: H1391-H1405.
51. Ding H, Triggle CR, (2010). Endothelial dysfunction in diabetes: multiple targets for treatment. Pflugers Arch 459: 977-994.
52. Dohi Y, Thiel MA, Buhler FR, Luscher TF, (1990). Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension 16: 170-179.
53. Dong LH, Lv P, Han M, (2012). Roles of SM22a in cellular plasticity and vascular diseases. Cardiovasc Hematol Disord Drug Targets 12: 119-125.
54. Du X, Edelstein D, Obici S, Higham N, Zou MH, Brownlee M, (2006). Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. J Clin Invest 116: 1071-1080.
55. Duckles SP, Miller VM, (2010). Hormonal modulation of endothelial NO production. Pflugers Arch 459: 841-851.
56. Edwards G, Feletou M, Weston AH, (2010). Endothelium-derived hyperpolarizing factors and associated pathways: a synopsis. Pflugers Arch 459: 863-879.
57. 2, thronboxane/prostaglandin (TP) receptors, and endothelium-derived hyperpolarization. Cardiovasc Res 102: 9-16.
58. Erlinge D, Burnstock G, (2008). P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4: 1-20.
59. Escalante B, Sessa WB, Flack JR, Yadagiri P, Schwartzman ML, (1989). Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J Pharmacol Exp Ther 248: 229-232.
60. Farhat MY, Wolfe R, Vargas R, Foegh ML, Ramwell PW, (1995). Effect of testosterone treatment on vasoconstrictor response of left anterior descending coronary artery in male and female pigs. J Cardiovasc Pharmacol 25: 495-500.
61. Favero G, Paganelli C, Buffoli B, Rodella LF, Rezzani R, (2014). Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int 2014: 801896.
62. Feletou M, (2009). Calcium-activated potassium channels and endothelial dysfunction: therapeutic options? Br J Pharmacol 156: 545-562.
63. Feletou M, Vanhoutte PM, (2004). EDHF: new therapeutic targets? Pharmacol Res 49: 565-580.
64. Feletou M, Tang EH, Vanhoutte PM, (2008). Nitric oxide the gatekeeper of endothelial vasomotor control. Front Biosci 13: 4198-4217.
65. Feletou M, Verbeuren TJ, Vanhoutte PM, (2009). Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 156: 563-574.
66. Feletou M, Huang Y, Vanhoutte PM, (2010a). Vasoconstrictor prostanoids. Pflugers Arch 459: 941-950.
67. Feletou M, Kohler R, Vanhoutte PM, (2010b). Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep 12: 267-275.
68. Feletou M, Huang Y, Vanhoutte PM, (2011). Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 164: 894-912.
69. Ferreira NS, Cau SB, Silva MA, Manzato CP, Mestriner FL, Matsumoto T, et al. (2015). Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation. Front Pharmacol 6: 34.
70. Flammer AJ, Luscher TF, (2010). Three decades of endothelium research: from the detection of nitric oxide to the everyday implementation of endothelial function measurements in cardiovascular diseases. Swiss Med Wkly 140: w13122.
71. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, et al. (2012). The assessment of endothelial function: from research into clinical practice. Circulation 126: 753-767.
72. Forbes JM, Cooper ME, (2013). Mechanisms of diabetic complications. Physiol Rev 93: 137-188.
73. Ford RJ, Rush JW, (2011). Endothelium-dependent vasorelaxation to the AMPK activator AICAR is enhanced in aorta from hypertensive rats and is NO and EDCF dependent. Am J Physiol Heart Circ Physiol 300: H64-H75.
74. Forstermann U, Li H, (2011). Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling. Br J Pharmacol 164: 213-223.
75. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM, (2004). Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369.
76. Francois H, Makhanova N, Ruiz P, Ellison J, Mao L, Rockman HA, et al. (2008). A role for the thromboxane receptor in L-NAME hypertension. Am J Physiol Renal Physiol 295: F1096-F1102.
77. Fukata Y, Amano M, Kaibuchi K, (2001). Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22: 32-39.
78. Furchgott RF, Zawadzki JV, (1980). The obligatory role of endothelial cells in the regulation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
79. Garcia-Redondo AB, Briones AM, Martinez-Revelles S, Palao T, Vila L, Alonso MJ, et al. (2015). c-Src, ERK1/2 and Rho kinase mediate hydrogen peroxide-induced vascular contraction in hypertension: role of TXA2, NAD(P)H oxidase and mitochondria. J Hypertens 33: 77-87.
80. Garland CJ, Hiley CR, Dora KA, (2011). EDHF: spreading the influence of the endothelium. Br J Pharmacol 164: 839-852.
81. Ge T, Hughes H, Junquero DC, Wu KK, Vanhoutte PM, Boulanger CM, (1995). Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res 76: 1003-1010.
82. Gelosa P, Ballerio R, Banfi C, Nobili E, Glanella A, Pignieri A, et al. (2010). Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin. J Pharmacol Exp Ther 334: 199-205.
83. Giannarelli C, Zafar MU, Badimon JJ, (2010). Prostanoid and TP-receptors in atherothrombosis: is there a role for their antagonism? Thromb Haemost 104: 949-954.
84. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M, (2005). Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146: 834-845.
85. Gluais P, Paysant J, Badier-Commander C, Verbeuren T, Vanhoutte PM, Feletou M, (2006). In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors. Am J Physiol Heart Circ Physiol 291: H2255-H2264.
86. Gluais P, Vanhoutte PM, Feletou M, (2007). Mechanisms underlying ATP-induced endothelium-dependent contractions in the SHR aorta. Eur J Pharmacol 556: 107-114.
87. Gomez E, Schwendemann C, Roger S, Simonet S, Paysant J, Courchay C, et al. (2008). Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats. Am J Physiol Heart Circ Physiol 295: H2198-H2211.
88. Gonzales RJ, Duckles SP, Krause DN, (2009). Dihydrotestosterone stimulates cerebrovascular inflammation through NFkappaB, modulating contractile function. J Cereb Blood Flow Metab 29: 244-253.
89. Goulopoulou S, Davidge ST, (2015). Molecular mechanisms of maternal vascular dysfunction in preeclampsia. Trends Mol Med 21: 88-97.
90. Goulopoulou S, Hannan JL, Matsumoto T, Webb RC, (2012). Pregnancy reduces RhoA/Rho kinase and protein kinase C signaling pathways downstream of thromboxane receptor activation in the rat uterine artery. Am J Physiol Heart Circ Physiol 302: H2477-H2488.
91. Grgic I, Kaistha BP, Hoyer J, Kohler R, (2009). Endothelial Ca2+-activated K+ channels in normal and impaired EDHF-dilator response-relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 157: 509-526.
92. Griffith TM, (2004). Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br J Pharmacol 141: 881-903.
93. Grosser T, Yu Y, Fitzgerald GA, (2010). Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med 61: 17-33.
94. Gui Y, Walsh MP, Jankowski V, Jankowski J, Zheng XL, (2008). Up4A stimulates endothelium-independent contraction of isolated rat pulmonary artery. Am J Physiol Lung Cell Mol Physiol 294: L733-L738.
95. Gui Y, He G, Walsh MP, Zheng XL, (2011). Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells. J Cardiovasc Pharmacol 58: 654-662.
96. Guo Z, Su W, Allen S, Pang H, Daugherty A, Smart E, et al. (2005). COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Cardiovasc Res 67: 723-735.
97. Han G, Li F, Yu X, White RE, (2013). GPER: a novel target for non-genomic estrogen action in the cardiovascular system. Pharmacol Res 71: 53-60.
98. Hansen PB, Hristovska A, Wolff H, Vanhoutte P, Jensen BL, Bie P, (2010). Uridine adenosine tetraphosphate affects contractility of mouse aorta and decreases blood pressure in conscious rats and mice. Acta Physiol (Oxf) 200: 171-179.
99. Hart EC, Charkoudian N, Miller VM, (2011). Sex, hormones and neuroeffector mechanisms. Acta Physiol (Oxf) 203: 155-165.
100. Hattori Y, Kawasaki H, Abe K, Kanno M, (1991). Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261: H1086-H1094.
101. Hayashi T, Yamada K, Esaki M, Kuzuya M, Satake S, Ishikawa T, et al. (1995). Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214: 847-855.
102. Hermenegildo C, Oviedo PJ, Cano A, (2006). Cyclooxygenases regulation by estradiol on endothelium. Curr Pharm Des 12: 205-215.
103. Hernanz R, Briones AM, Salaices M, Alonso MJ, (2014). New roles for old pathways? A circuitous relationship between reactive oxygen species and cyclo-oxygenase in hypertension. Clin Sci 126: 111-121.
104. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T, (1995). Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 360: 291-293.
105. Hollenberg SM, Tong W, Shelhamer JH, Lawrence M, Cunnion RE, (1994). Eicosanoid production by human aortic endothelial cells in response to endothelin. Am J Physiol 267: H2290-H2296.
106. Hopkins PN, (2013). Molecular biology of atherosclerosis. Physiol Rev 93: 1317-1542.
107. Huang A, Sun D, Kaley G, Koller A, (1997). Estrogen maintains nitric oxide synthesis in arterioles of female hypertensive rats. Hypertension 29: 1351-1356.
108. Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, et al. (1997). Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol 29: 800-807.
109. Huxley VH, Wang J, (2010). Cardiovascular sex differences influencing microvascular exchange. Cardiovasc Res 87: 230-242.
110. Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T, (2011). Mechanisms underlying altered extracellular nucleotide-induced contractions in mesenteric arteries from rats in later-stage type 2 diabetes: effect of ANG II type 1 receptor antagonism. Am J Physiol Heart Circ Physiol 301: H1850-H1861.
111. Ishida K, Matsumoto T, Taguchi K, Kamata K, Kobayashi T, (2012). Pravastatin normalizes endothelium-derived contracting factor-mediated response via suppression of Rho-kinase signalling in mesenteric artery from aged type 2 diabetic rat. Acta Physiol (Oxf) 205: 255-265.
112. Jankowski V, Tolle M, Vanholder R, Schonfelder G, van der Giet M, Henning L, et al. (2005). Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor. Nat Med 11: 223-227.
113. Jankowski V, Meyer AA, Schlattmann P, Gui Y, Zhang XL, Stamcou I, et al. (2007). Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives. Arterioscler Thromb Vasc Biol 27: 1776-1781.
114. Jankowski V, Schulz A, Kretschmer A, Mischak H, Boehringer F, van der Giet M, et al. (2013). The enzymatic activity of the VEGFR2 receptor for the biosynthesis of dinucleotide polyphosphates. J Mol Med 91: 1095-1107.
115. Jerez S, Sierra L, Coviello A, de Bruno MP, (2008). Endothelial dysfunction and improvement of the angiotensin II-reactivity in hypercholesterolemic rabbits: role of cyclooxygenase metabolites. Eur J Pharmacol 580: 182-189.
116. Jones RL, Giembycz MA, Woodward DF, (2009). Prostanoid receptor antagonists: development strategies and therapeutic applications. Br J Pharmacol 158: 104-145.
117. Kahonen M, Tolvanen JP, Sallinen K, Wu X, Porsti I, (1998). Influence of gender on control of arterial tone in experimental hypertension. Am J Physiol 44: H15-H22.
118. Kamata K, Kobayashi T, (1996). Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br J Pharmacol 119: 583-589.
119. Kamata K, Miyata N, Kasuya Y, (1989). Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 97: 614-618.
120. Kassan M, Choi SK, Galan M, Biship A, Umezawa K, Trebak M, et al. (2013). Enhanced NF-kB activity impairs vascular function through PARP-1-, SP-1-, and COX-2-dependent mechanisms in type 2 diabetes. Diabetes 62: 2078-2087.
121. Katusic ZS, Vanhoutte PM, (1989). Superoxide anion is an endothelium-derived contracting factor. Am J Physiol 257: H33-H37.
122. Katusic ZS, Shepherd JT, Vanhoutte PM, (1988). Endothelium-dependent contractions to calcium ionophore A23187, arachidonic acid and acetylcholine in canine basilar arteries. Stroke 19: 476-479.
123. Kauser K, Rubanyi GM, (1995). Gender differences in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension 25: 517-523.
124. Kawka DW, Ouellet M, Hetu PO, Singer II, Riendeau D, (2007). Double-label expression studies of prostacyclin synthase, thromboxane synthase and COX isoforms in normal aortic endothelium. Biochim Biophys Acta 1771: 45-54.
125. Keen HL, Brands MW, Smith MJ Jr, Shek EW, Hall JE, (1997). Thromboxane is required for full expression of angiotensin hypertension in rats. Hypertension 29: 310-314.
126. Khalil RA, (2005). Sex hormones as potential modulators of vascular function in hypertension. Hypertension 46: 249-254.
127. Kittikulsuth W, Sullivan JC, Pollock DM, (2013). ET-1 actions in the kidney: evidence for sex differences. Br J Pharmacol 168: 318-326.
128. Kobayashi T, Matsumoto T, Kamata K, (2000). Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats. Br J Pharmacol 131: 231-238.
129. Kobayashi T, Nogami T, Taguchi K, Matsumoto T, Kamata K, (2008). Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK. Br J Pharmacol 155: 974-983.
130. Korbecki J, Baranowska-Bosiacka I, Gutowska I, Chlubek D, (2013). The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J Physiol Pharmacol 64: 409-421.
131. Kraskiewicz H, FitzGerald U, (2012). Interfering with endoplasmic reticulum stress. Trends Pharmacol Sci 33: 53-63.
132. Lempiäinen J, Finckenberg P, Levijoki J, Mervaala E, (2012). AMPK activator AICAR ameliorates ischaemia reperfusion injury in the rat kidney. Br J Pharmacol 166: 1905-1915.
133. Li M, Stallone JN, (2005). Estrogen potentiates vsopressin-induced contraction of female rat aorta by enhancing cyclooxygenase-2 and thromboxane function. Am J Physiol Heart Circ Physiol 289: H1542-H1550.
134. Li M, Kuo L, Stallone JN, (2008). Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Am J Physiol Heart Circ Physiol 294: H2444-H2455.
135. Li Z, Wang Y, Vanhoutte PM, (2011). Upregulation of heme oxygenase 1 by hemin impairs endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Hypertension 58: 926-934.
136. Linder AE, Tumbri M, Linder FF, Webb RC, Leite R, (2008). Uridine adenosine tetraphosphate induces contraction and relaxation in rat aorta. Vascul Pharmacol 48: 202-207.
137. Liu CQ, Leung FP, Wong SL, Wong WT, Lau CW, Lu L, et al. (2009). Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Biochem Pharmacol 78: 374-381.
138. Lopez-Lopez JG, Moral-Sanz J, Frazziano G, Gomez-Villalobos MJ, Moreno L, Menendez C, et al. (2011). Type 1 diabetes-induced hyper-responsiveness to 5-hydroxytryptamine in rat pulmonary arteries via oxidative stress and induction of cyclooxygenase-2. J Pharmacol Exp Ther 338: 400-407.
139. Maguire JJ, Davenport AP, (2014). Endothelin@25-new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12. Br J Pharmacol 171: 5555-5572.
140. Manrique C, Lastra G, Sowers JR, (2014). New insights into insulin action and resistance in the vasculature. Ann N Y Acad Sci 1311: 135-150.
141. Marrachelli VG, Miranda FJ, Centeno JM, Salom JB, Torregrosa G, Jover-Mengual T, et al. (2010). Role of NO-synthases and cyclooxygenases in the hyperreactivity of male rabbit carotid artery to testosterone under experimental diabetes. Pharmacol Res 61: 62-70.
142. Martinez AC, Hernandez M, Novella S, Martinez MP, Pagan RM, Hermenegildo C, et al. (2014). Diminished neurogenic femoral artery vasoconstrictor response in a Zucker obese rat model: differential regulation of NOS and COX derivatives. PLoS ONE 9: e106372.
143. Masuda A, Mathur R, Halushka PV, (1991). Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells. Circ Res 69: 638-643.
144. Matsumoto T, Kakami M, Noguchi E, Kobayashi T, Kamata K, (2007a). Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of Type 2 diabetes. Am J Physiol Heart Circ Physiol 293: H1480-H1490.
145. Matsumoto T, Noguchi E, Kobayashi T, Kamata K, (2007b). Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats. Free Radic Biol Med 42: 993-1007.
146. Matsumoto T, Kobayashi T, Kamata K, (2008a). Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals. J Smooth Muscle Res 44: 41-55.
147. Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, Kamata K, (2008b). Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 295: H1165-H1176.
148. Matsumoto T, Ishida K, Kobayashi T, Kamata K, (2009a). Pyrrolidine dithiocarbamate reduces vascular prostanoid-induced responses in aged type 2 diabetic rat model. J Pharmacol Sci 110: 326-333.
149. Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K, (2009b). Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J Pharmacol Exp Ther 329: 324-334.
150. Matsumoto T, Takaoka E, Ishida K, Nakayama N, Noguchi E, Kobayashi T, et al. (2009c). Abnormalities of endothelium-dependent responses in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats are improved by chronic treatment with thromboxane A2 synthase inhibitor. Atherosclerosis 205: 87-95.
151. Matsumoto T, Ishida K, Nakayama N, Taguchi K, Kobayashi T, Kamata K, (2010). Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats. Pharmacol Res 62: 271-281.
152. Matsumoto T, Tostes RC, Webb RC, (2011a). The role of uridine adenosine tetraphosphate in the vascular system. Adv Pharmacol Sci 2011: 435132.
153. Matsumoto T, Tostes RC, Webb RC, (2011b). Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 301: H409-H417.
154. Matsumoto T, Tostes RC, Webb RC, (2012). Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats. Pharmacol Res 65: 81-90.
155. Matsumoto T, Lopes RA, Taguchi K, Kobayashi T, Tostes RC, (2014a). Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system. Life Sci 118: 129-135.
156. Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T, (2014b). Enhanced uridine adenosine tetraphosphate-induced contraction in renal artery from type 2 diabetic Goto-Kakizaki rats due to activated cyclooxygenase/thromboxane receptor axis. Pflugers Arch 466: 331-342.
157. Meagher EF, FitzGerald GA, (1993). Disordered eicosanoid formation in pregnancy-induced hypertension. Circulation 88: 1324-1333.
158. Meyer MC, Cummings K, Osol G, (1997). Estrogen replacement attenuates resistance artery adrenergic sensitivity via endothelial vasodilators. Am J Physiol 272: H2264-H2270.
159. Meyer MR, Prossnitz ER, Barton M, (2011). The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function. Vascul Pharmacol 55: 17-25.
160. Meyer MR, Amann K, Field AS, Hu C, Hathaway HJ, Kanagy NL, et al. (2012). Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction. Hypertension 59: 507-512.
161. Miao CY, Li ZY, (2012). The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 165: 643-658.
162. Michel F, Simonet S, Vayssettes-Courchay C, Bertin F, Sansilvestri-Morel P, Bernhardt F, et al. (2008b). Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice. Am J Physiol Renal Physiol 294: F120-F129.
163. Michel FS, Man GS, Man RY, Vanhoutte PM, (2008a). Hypertension and the absence of EDHF-mediated responses favour endothelium-dependent contractions in renal arteries of the rat. Br J Pharmacol 155: 217-226.
164. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L, Ylikorkala O, (1995). 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 80: 1832-1836.
165. Miller VM, Mulvagh SL, (2007). Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci 28: 263-270.
166. Miller VM, Vanhoutte PM, (1990). 17 Beta-estradiol augments endothelium-dependent contractions to arachidonic acid in rabbit aorta. Am J Physiol 258: R1502-R1507.
167. Miyata N, Roman RJ, (2005). Role of 20-hydroxyeicosapentaenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41: 175-193.
168. Mukohda M, Okada M, Hara Y, Yamawaki H, (2012). Methylglyoxal accumulation in arterial walls causes vascular contractile dysfunction in spontaneously hypertensive rats. J Pharmacol Sci 120: 26-35.
169. Nacci C, Tarquinio M, De Benedictis L, Mauro A, Zigrino A, Carratu MR, et al. (2009). Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. Endocrinology 150: 849-861.
170. Naik V, Leaf EM, Hu JH, Yang HY, Nguyen NB, Giacheli CM, et al. (2012). Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study. Cardiovasc Res 94: 545-554.
171. Nakahata N, (2008). Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther 118: 18-35.
172. Nakano T, (2015). Roles of lipid-modulating enzymes diacylglycerol kinase and cyclooxygenase under pathophysiological conditions. Anat Sci Int 90: 22-32.
173. Narumiya S, Sugimoto Y, Ushikubi F, (1999). Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226.
174. Ndisang JF, Wang R, Vannacci A, Marzocca C, Fantappie O, Mazzanti R, et al. (2001). Haeme oxygenase-1 and cardiac anaphylaxis. Br J Pharmacol 134: 1689-1696.
175. Nie H, Wu JL, Zhang M, Xu J, Zou MH, (2006). Endothelial nitric oxide synthase-dependent tyrosine nitration of prostacyclin synthase in diabetes in vivo. Diabetes 55: 3133-3141.
176. Nilsson BO, Olde B, Leeb-Lundberg LM, (2011). G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling. Br J Pharmacol 163: 1131-1139.
177. Nobe K, Nezu Y, Tsumita N, Hashimoto T, Honda K, (2008). Intra- and extrarenal arteries exhibit different profiles of contractile responses in high glucose conditions. Br J Pharmacol 155: 1204-1213.
178. Numaguchi Y, Harada M, Osanai H, Hayashi K, Toki Y, Okumura K, et al. (1999). Altered gene expression of prostacyclin synthase and prostacyclin receptor in the thoracic aorta of spontaneously hypertensive rats. Cardiovasc Res 41: 682-688.
179. Nunes KP, Rigsby CS, Webb RC, (2010). RhoA/Rho-kinase and vascular diseases: what is the link? Cell Mol Life Sci 67: 3823-3836.
180. Okon EB, Golbabaie A, van Breemen C, (2002). In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors. Br J Pharmacol 137: 545-553.
181. Orshal JM, Khalil RA, (2004). Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286: R233-R249.
182. Ospina JA, Duckles SP, Krause DN, (2003). 17Beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol 285: H241-H250.
183. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR. (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
184. Pries AR, Kuebler WM, (2006). Normal endothelium. Handb Exp Pharmacol 176: 1-40.
185. Prossnitz ER, Barton M, (2011). The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7: 715-726.
186. Qu C, Leung SW, Vahnoutte PM, Man RY, (2010). Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2. J Pharmacol Exp Ther 334: 373-380.
187. Quilley J, Chen YJ, (2003). Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. Hypertension 42: 837-843.
188. Ragolia L, Palaia T, Hall CE, Maesaka JK, Eguchi N, Urade Y, (2005). Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J Biol Chem 280: 29946-29955.
189. Ramos-Alves FE, de Queiroz DB, Santos-Rocha J, Duarte GP, Xavier FE, (2012a). Effect of age and COX-2-derived prostanoids on the progression of adult vascular dysfunction in the offspring of diabeic rats. Br J Pharmacol 166: 2198-2208.
190. Ramos-Alves FE, de Queiroz DB, Santos-Rocha J, Duarte GP, Xavier FE, (2012b). Increased cyclooxygenase-2-derived prostanoids contributes to the hyperreactivity to noradrenaline in mesenteric resistance arteries from offspring of diabetic rats. PLoS ONE 7: e50593.
191. Randriamboavonjy V, Busse R, Fleming I, (2003). 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 41: 801-806.
192. Rapoport RM, Williams SP, (1996). Role of prostaglandins in acetylcholine-induced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 28: 64-75.
193. Rask-Madsen C, King GL, (2007). Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 3: 46-56.
194. Rask-Madsen C, King GL, (2013). Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab 17: 20-33.
195. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER, (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
196. Roman RJ, (2002). P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185.
197. Rouzer CA, Marnett LJ, (2009). Cyclooxygenases: structural and functional insights. J Lipid Res 50: S29-S34.
198. Rovati GE, Sala A, Capra V, Dahlen SE, Folco G, (2010). Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk. Trends Pharmacol Sci 31: 102-107.
199. Salvemini D, Kim SF, Mollace V, (2013). Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications. Am J Physiol Regul Integr Comp Physiol 304: R473-R487.
200. Sanchez A, Contreras C, Villalba N, Martinez P, Martinez AC, Briones A, et al. (2010). Altered arachidonic acid metabolism via COX-1 and COX-2 contributes to the endothelial dysfunction of penile arteries from obese Zucker rats. Br J Pharmacol 159: 604-616.
201. Sandoval YH, Atef ME, Levesque LO, Li Y, Anand-Srivastava MB, (2014). Endothelin-1 signaling in vascular physiology and pathophysiology. Curr Vasc Pharmacol 12: 202-214.
202. Scatena M, Liaw L, Giachelli CM, (2007). Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27: 2302-2309.
203. Schror K, Morinelli TA, Masuda A, Matsuda K, Mathur RS, Halushka PV, (1994). Testosterone treatment enhances thromboxane A2 mimetic induced coronary artery vasoconstriction in guinea pigs. Eur J Clin Invest 24: 50-52.
204. Schuchardt M, Prufer J, Prufer N, Wiedon A, Huang T, Chebli M, et al. (2011). The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J Mol Med 89: 799-810.
205. Schuchardt M, Tolle M, Prufer J, Prufer N, Huang T, Jankowski V, et al. (2012). Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification. Kidney Int 81: 256-265.
206. Schwartzman ML, Falck JR, Yadagiri P, Escalante B, (1989). Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J Biol Chem 264: 11658-11662.
207. Sena CM, Pereira AM, Seica R, (2013). Endothelial dysfunction-a major mediator of diabetic vascular disease. Biochim Biophys Acta 1832: 2216-2231.
208. Sherman TS, Chambliss KL, Gibson LL, Pace MC, Mendelsohn ME, Pfister SL, et al. (2002). Estrogen acutely activates prostacyclin synthesis in ovine fetal pulmonary artery endothelium. Am J Respir Cell Mol Biol 26: 610-616.
209. Sheu ML, Ho FM, Yang RS, Chao KF, Lin WW, Lin-Shiau SY, et al. (2005). High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arterioscler Thromb Vasc Biol 25: 539-545.
210. Shi Y, Vanhoutte PM, (2008). Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 154: 639-651.
211. Shi Y, Feletou M, Ku DD, Man RY, Vanhoutte PM, (2007). The calcium ionophore A23187 induces endothelium-dependent contractions in femoral arteries from rats with streptozotocin-induced diabetes. Br J Pharmacol 150: 624-632.
212. Shi Y, Man RY, Vanhoutte PM, (2008). Two isoforms of cyclooxygenase contribute to augmented endothelium-dependent contractions in femoral arteries of 1-year old rats. Acta Pharmacol Sin 29: 185-192.
213. Siller-Matula JM, Krumphuber J, Jilma B, (2010). Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases. Br J Pharmacol 59: 502-517.
214. Simmons DL, Botting RM, Hla T, (2004). Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-437.
215. Sobrino A, Oviedo PJ, Novella S, Laguna-Fernandez A, Bueno C, Garcia-Perez MA, et al. (2010). Estradiol selectively stimulates endothelial prostacyclin production through estrogen receptor-{alpha}. J Mol Endocrinol 44: 237-246.
216. Somlyo AP, Somlyo AV, (2000). Signal transduction by G-proteins, Rho kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522: 177-185.
217. Somlyo AP, Somlyo AV, (2003). Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases and myosin phosphatase. Physiol Rev 83: 1325-1358.
218. Song D, Arikawa E, Galipeau D, Battell M, McNeill JH, (2004). Androgens are necessary for the development of fructose-induced hypertension. Hypertension 43: 667-672.
219. Sparks MA, Makhanova NA, Griffiths RC, Snouwaert JN, Koller BH, Coffman TM, (2013). Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death. Hypertension 61: 166-173.
220. Spitler KM, Matsumoto T, Webb RC, (2013). Suppression of endoplasmic reticulum stress improves endothelium-dependent contractile responses in aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 305: H344-H353.
221. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, et al. (2001). Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 89: 1147-1154.
222. Sullivan JC, Sasser JM, Pollock DM, Pollock JS, (2005). Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats. Hypertension 45: 406-411.
223. Szabo C, (2009). Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol 156: 713-727.
224. Taba Y, Sasaguri T, Miyagi M, Abumiya T, Miwa Y, Ikeda T, et al. (2000). Fluid shear stress induces lipocalin-type prostaglandin D2 synthase in vascular endothelial cells. Circ Res 86: 967-973.
225. Taddei S, Vanhoutte PM, (1993). Role of endothelium in endothelin-evoked contractions in the rat aorta. Hypertension 21: 9-15.
226. Taddei S, Virdis A, Mattei P, Salvetti A, (1993). Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21: 929-933.
227. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A, (1998). Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229.
228. Taddei S, Virdis A, Ghiadoni L, Salvetti A, (2000). Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide. J Cardiovasc Pharmacol 35: S37-S40.
229. Taguchi K, Hida M, Matsumoto T, Ikeuchi-Takahashi Y, Onishi H, Kobayashi T, (2014). Effect of short-term polyphenol treatment on endothelial dysfunction and thromboxane A2 levels in streptozotocin-induced diabetic mice. Biol Pharm Bull 37: 1056-1061.
230. Takada Y, Kato C, Kondo S, Korenaga R, Ando J, (1997). Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem Biophys Res Commun 240: 737-741.
231. Tang EH, Vanhoutte PM, (2008). Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol Genomics 32: 409-418.
232. Tang EH, Vanhoutte PM, (2009). Prostanoids and reactive oxygen species: team players in endothelium-dependent contractions. Pharmacol Ther 122: 140-149.
233. Tang EH, Vanhoutte PM, (2010). Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Arch 459: 995-1004.
234. Tang EH, Feletou M, Huang Y, Man RY, Vanhoutte PM, (2005a). Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-mediated contractions. Am J Physiol Heart Circ Physiol 289: H2434-H2440.
235. Tang EH, Ku DD, Tipoe GL, Feletou M, Man RY, Vanhoutte PM, (2005b). Endothelium-dependent contractions occur in the aorta of wild-type and COX2-/- knockout but not COX1-/- knockout mice. J Cardiovasc Pharmacol 46: 761-765.
236. Tang EH, Leung FP, Huang Y, Feletou M, So KF, Man RY, et al. (2007). Calcium and reactive oxygen species increase in endothelial cells in response to releasers of endothelium-derived contracting factor. Br J Pharmacol 151: 15-23.
237. Tang EH, Jensen BL, Skott O, Leung GP, Feletou M, Man RY, et al. (2008). The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res 78: 130-138.
238. Tejera N, Balfagon G, Marin J, Ferrer M, (1999). Gender differences in the endothelial regulation of alpha2-adrenoceptor-mediated contraction in the rat aorta. Clin Sci 97: 19-25.
239. Toda N, Imamura T, Okamura T, (2010). Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus. Pharmacol Ther 127: 189-209.
240. Toda N, Nakanishi S, Tanabe S, (2013). Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications. Br J Pharmacol 168: 519-533.
241. Tolle M, Schuchardt M, Wiedon A, Huang T, Klockel L, Jankowski J, et al. (2010). Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol 161: 530-540.
242. Tostes RC, Nigro D, Fortes ZB, Carvalho MH, (2003). Effects of estrogen on the vascular system. Braz J Med Biol Res 36: 1143-1158.
243. Tostes RC, Fortes ZB, Callera GE, Montezano AC, Touyz RM, Webb RC, et al. (2008). Endothelin, sex and hypertension. Clin Sci 114: 85-97.
244. Toth P, Rozsa B, Springo Z, Doczi T, Koller A, (2011). Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors. J Cereb Blood Flow Metab 31: 2096-2105.
245. Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C, (2012). The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 10: 4-18.
246. Touyz RM, Schiffrin EL, (2004). Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122: 339-352.
247. Traupe T, Lang M, Goettsch W, Munter K, Morawietz H, Vetter W, et al. (2002). Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 20: 2239-2245.
248. Triggle CR, Howarth A, Cheng ZJ, Ding H, (2005). Twenty-five years since the discovery of endothelium-derived relaxing factor (EDRF): does a dysfunctional endothelium contribute to the development of type 2 diabetes? Can J Physiol Pharmacol 83: 681-700.
249. Valentin F, Field MC, Tippins JR, (2004). The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem 279: 8316-8324.
250. Vanhoutte PM, (2009). COX-1 and vascular disease. Clin Pharmacol Ther 86: 212-215.
251. Vanhoutte PM, (2011). Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension 57: 526-531.
252. Vanhoutte PM, Tang EH, (2008). Endothelium-dependent contractions: when a good guy turns bad! J Physiol 586: 5295-5304.
253. Vanhoutte PM, Feletou M, Taddei S, (2005). Endothelium-dependent contractions in hypertension. Br J Pharmacol 144: 449-458.
254. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M, (2009). Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196: 193-222.
255. Vapaatalo H, Mervaala E, (2001). Clinically important factors influencing endothelial function. Med Sci Monit 7: 1075-1085.
256. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S, (2009). Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol 157: 527-536.
257. Vessieres E, Guihot AL, Toutain B, Maquigneau M, Fassot C, Loufrani L, et al. (2013). COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats. PLoS ONE 8: e68217.
258. Villalba N, Contreras C, Hernandez M, Garcia-Sacristan A, Prieto D, (2011). Impaired Ca2+ handling in penile arteries from prediabetic Zucker rats: involvement of Rho kinase. Am J Physiol Heart Circ Physiol 300: H2044-H2053.
259. Virdis A, Ghiadoni L, Taddei S, (2010). Human endothelial dysfunction: EDCFs. Pflugers Arch 459: 1015-1023.
260. Wang Y, Ying L, Chen YY, Shen YL, Guo R, Jin KK, et al. (2014). Induction of heme oxygenase-1 ameliorates vascular dysfunction in streptozotocin-induced type 2 diabetic rats. Vascul Pharmacol 61: 16-24.
261. Wiedon A, Tolle M, Bastine J, Schuchardt M, Huang T, Jankowski V, et al. (2012). Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor. Biochem Biophys Res Commun 417: 1035-1040.
262. Williams SP, Shackelford DP, Iams SG, Mustafa SJ, (1988). Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur J Pharmacol 145: 205-207.
263. Wilson DP, Susnjar M, Kiss E, Sutherland C, Walsh MP, (2005). Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697. Biochem J 389: 763-774.
264. Wilson SJ, Cavanagh CC, Lesher AM, Frey AJ, Russell SE, Smyth EM, (2009). Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species. J Lipid Res 50: 1047-1056.
265. Wong MS, Vanhoutte PM, (2010). COX-mediated endothelium-dependent contractions: from the past to recent discoveries. Acta Pharmacol Sin 31: 1095-1102.
266. Wong MS, Man RY, Vanhoutte PM, (2010a). Calcium-independent phospholipase A(2) plays a key role in the endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 298: H1260-H1266.
267. Wong SL, Leung FP, Lau CW, Au CL, Yung LM, Yao X, et al. (2009). Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contraction in the aortae of hamsters with increased impact during aging. Circ Res 104: 228-235.
268. Wong SL, Wong WT, Tian XY, Lau CW, Huang Y, (2010b). Prostaglandins in action indispensable roles of cyclooxygenase-1 and -2 in endothelium-dependent contractions. Adv Pharmacol 60: 61-83.
269. Woodward DF, Jones RL, Narumiya S, (2011). International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 63: 471-538.
270. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415.
271. Yang D, Feletou M, Boulanger CM, Wu HF, Levens N, Zhang JN, et al. (2002). Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br J Pharmacol 136: 104-110.
272. Yang D, Feletou M, Levens N, Zhang JN, Vanhoutte PM, (2003a). A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR. Hypertension 41: 143-148.
273. Yang D, Levens N, Zhang JN, Vanhotte PM, Feletou M, (2003b). Specific potentiation of endothelium-dependent contractions in SHR by tetrahydrobiopterin. Hypertension 41: 136-142.
274. Yang D, Gluais P, Zhang JN, Vanhoutte PM, Feletou M, (2004a). Endothelium-dependent contractions to acetylcholine, ATP and the calcium ionophore A23187 in aortas from spontaneously hypertensive and normotensive rats. Fundam Clin Pharmacol 18: 321-326.
275. Yang D, Gluais P, Zhang JN, Vanhoutte PM, Feletou M, (2004b). Nitric oxide and inactivation of the endothelium-dependent contracting factor released by acetylcholine in spontaneously hypertensive rat. J Cardiovasc Pharmacol 43: 815-820.
276. Yang XQ, Wang YY, Chen AF, (2008). Increased superoxide contributes to enhancement of vascular contraction in Ins2(Akita) diabetic mice, an autosomal dominant mutant model. Clin Exp Pharmacol Physiol 35: 1097-1103.
277. Yates CM, Calder PC, Ed Rainger G, (2014). Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacol Ther 141: 272-282.
278. Zhang L, Kosaka H, (2002). Sex-specific acute effect of estrogen on endothelium-derived contracting factor in the renal artery of hypertensive Dahl rats. J Hypertens 20: 237-246.
279. Zhang M, Dong Y, Xu J, Xie Z, Wu Y, Song Y, et al. (2008). Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ Res 102: 328-337.
280. Zhou MS, Kosaka H, Tian RX, Abe Y, Chen QH, Yoneyama H, et al. (2001). L-arginine improves endothelial function in renal artery of hypertensive Dahl rats. J Hypertens 19: 421-429.
281. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL, (2005). Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289: H1027-H1032.
282. Zhou Z, Merkus D, Cheng C, Duckers HJ, Jan Danser AH, Duncker DJ, (2013). Uridine adenosine tetraphosphate is a novel vasodilator in the coronary microcirculation which acts through purinergic P1 but not P2 receptors. Pharmacol Res 67: 10-17.
283. Zhu N, Liu B, Luo W, Zhang Y, Li H, Li S, et al. (2014). Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin. Am J Physiol Heart Circ Physiol 307: H319-H327.
284. Zou MH, (2007). Peroxynitrite and protein tyrosine nitration of prostacyclin. Prostaglandins Other Lipid Mediat 82: 119-127.
285. Zou MH, Shi C, Cohen RA, (2002). High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51: 198-203.
286. Zou MH, Cohen R, Ullrich V, (2004). Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11: 89-97.
287. Zuccollo A, Shi C, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, Zang M, et al. (2005). The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus. Circulation 112: 3001-3008.